Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

GNTA

GNTA News

Newswire

04:59

Genenta Science shares surge 10.71% premarket as TEM-GBM study shows 44% 18-month survival rate and expansion into renal cell carcinoma trials.

04:03

Genenta Science Reports Consistent Survival Metrics for TEM-GBM Study Patients.

23:59

PACS Group and Nutex Health Lead Earnings Momentum After Hours, Zynex and Genenta Advance

12:02

Genenta Science (GNTA) down more than 80% since Oct 24

15:47

Genenta Science's 15min chart shows MACD Death Cross, Bearish Marubozu signal.

View More

About GNTA

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More